• Anti-Cd38 antibody [NIMR5] {APC} (STJA0002104)

Anti-Cd38 antibody [NIMR5] {APC} (STJA0002104)

SKU:
STJA0002104

Current Stock:
Host: Rat
Applications: FC
Reactivity: Mouse
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Short Description: Rat monoclonal antibody anti-ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 is suitable for use in Flow Cytometry research applications.
Clonality: Monoclonal
Clone ID: NIMR5
Conjugation: APC
Isotype: IgG2ak
Formulation: PBS with 0.05% Proclin300, 1% BSA
Storage Instruction: Recommend storing between 2-8°C and protecting from prolonged exposure to light. Do not freeze this product.
Gene Symbol: Cd38
Gene ID: 12494
Uniprot ID: CD38_MOUSE
Function Synthesizes the second messengers cyclic ADP-ribose (cADPR) and nicotinate-adenine dinucleotide phosphate (NAADP), the former a second messenger for glucose-induced insulin secretion, the latter a Ca(2+) mobilizer. Also has cADPR hydrolase activity.
Protein Name Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1
2'-Phospho-Adp-Ribosyl Cyclase
2'-Phospho-Adp-Ribosyl Cyclase/2'-Phospho-Cyclic-Adp-Ribose Transferase
2'-Phospho-Cyclic-Adp-Ribose Transferase
Adp-Ribosyl Cyclase 1
Adprc 1
Cyclic Adp-Ribose Hydrolase 1
Cadpr Hydrolase 1
I-19
Nim-R5 Antigen
Cd Antigen Cd38
Database Links Reactome: R-MMU-196807
Cellular Localisation Membrane
Single-Pass Type Ii Membrane Protein
Alternative Antibody Names Anti-Adp-Ribosyl Cyclase/Cyclic Adp-Ribose Hydrolase 1 antibody
Anti-2'-Phospho-Adp-Ribosyl Cyclase antibody
Anti-2'-Phospho-Adp-Ribosyl Cyclase/2'-Phospho-Cyclic-Adp-Ribose Transferase antibody
Anti-2'-Phospho-Cyclic-Adp-Ribose Transferase antibody
Anti-Adp-Ribosyl Cyclase 1 antibody
Anti-Adprc 1 antibody
Anti-Cyclic Adp-Ribose Hydrolase 1 antibody
Anti-Cadpr Hydrolase 1 antibody
Anti-I-19 antibody
Anti-Nim-R5 Antigen antibody
Anti-Cd Antigen Cd38 antibody
Anti-Cd38 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance